Clinical Trial Update: Role of Rosiglitazone on Pre-Diabetes Mellitus and Coronary Artery Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating rosiglitazone for prediabetes and coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Glucose Intolerance
• Insulin Resistance
• Prediabetes

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Prediabetes, Coronary Artery Disease | Phase 3 | Status: COMPLETED